Search results
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 weeks agoThe licensing agreement will allow Novavax to lift its "going concern" warning, which it first...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 2 weeks agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel ...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 1 week agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. ...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 2 weeks agoThe partnership with Sanofi allows Novavax Inc (NVAX) to leverage Sanofi's extensive global vaccine business expertise, potentially leading to hundreds ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 2 weeks agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 2 weeks agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance· 2 weeks agoWhile Novavax's vaccine did finally reach the market in mid-2022 targeting the booster...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 week ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Why Is Novavax (NVAX) Stock Up 118% Today?
InvestorPlace· 2 weeks agoNovavax (NASDAQ:NVAX) stock is on the rise Friday after the biotechnology company announced a deal with Sanofi (NASDAQ:SNY) alongside its first-quarter earnings report. The ...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 days agoConsidering Sanofi's focus on vaccine development, this could result in major growth for Matrix-M... let's get back to our question: Is it too late to...